Rivaroxaban significantly inhibits the stimulatory effects of bone-modulating hormones: In vitro study of primary female osteoblasts.

Abstract

BACKGROUND Anticoagulant therapy is a mainstay of treatment subsequent to major orthopedic surgeries. Evidence linking anticoagulant therapy, osteoporosis, and delayed fracture healing is not conclusive. We have previously reported that rivaroxaban significantly inhibited cell growth and energy metabolism in a human osteoblastic cell line. This study… (More)
DOI: 10.1080/03008207.2016.1220942

Topics

Cite this paper

@article{Somjen2017RivaroxabanSI, title={Rivaroxaban significantly inhibits the stimulatory effects of bone-modulating hormones: In vitro study of primary female osteoblasts.}, author={Dalia Somjen and Zachary T Sharfman and Sara Katzburg and Orli Sharon and Eran Maman and Moshe Salai and Naftali Stern and Oleg Dolkart}, journal={Connective tissue research}, year={2017}, volume={58 2}, pages={215-220} }